Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Gossamer Bio

Tracked across 2 events · 40 articles · First seen Apr 01, 2026 · Last active Jun 17, 2026

Sentiment
-52
Attention
2
Events
2
Relationships
10
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -65
Business
Impact: Gossamer Bio is subject to a class action lawsuit because its Phase 3 PROSERA study allegedly failed to meet its primary endpoint due to patient demographics at Latin American sites, leading to misleading positive statements.
May 18, 2026 · 20 articles
2 -40
Regulatory
Impact: Gossamer Bio is facing a class action lawsuit due to allegations that its Phase 3 PROSERA study failed to meet its primary endpoint, leading to misleading positive statements.
May 18, 2026 · 20 articles
68 Gossamer Bio failed to meet endpointMultiple Class Action...
Lawrence Rosen Gossamer Bio
Lawrence Rosen Gossamer Bio
Philip Kim Gossamer Bio
Philip Kim Gossamer Bio
Rosen Law Firm Gossamer Bio
Rosen Law Firm Gossamer Bio
Nasdaq-100 Gossamer Bio
Nasdaq-100 Gossamer Bio
ERGEN INTELLIGENCE
Track Gossamer Bio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.